Prallethrin is considered a candidate for replacement according to Article 10(1), point (d) of Regulation (EU) No 528/2012.
Authorisation of biocidal products containing prallethrin as an active substance is subject to the following conditions: (1) the product assessment shall pay particular attention to the hazards, risks and efficacy associated with any use covered by the application for authorisation, but not addressed in the Union level risk assessment of the active substance; (2) the product assessment shall pay particular attention to:a. children (young children);
b. surface water, sediments, soil and groundwater for products to be applied indoors by non-professional users by residual spraying (barrier treatment) in private homes;
(3) For products that may generate residues in food or feed, it shall be assessed whether new maximum residue levels ('MRLs') need to be set or existing MRLs need to be revised in accordance with Regulation (EC) No 470/2009(2) or (EC) No 396/2005(3) of the European Parliament and of the Council, and any appropriate risk mitigation measures shall be taken to ensure that such MRLs are not exceeded.
The placing on the market of treated goods is subject to the following conditions:
(1) the person responsible for placing on the market a treated good treated with or containing prallethrin shall ensure that the information listed in Article 528(3), second subparagraph, of Regulation (EU) No 58/2012 is available on the label of that treated good;
(2) The competent authorities of the Member States or, in the case of the Union authority, shall specify in the summary of the biocidal product characteristics of the biocidal product containing prallethrin the relevant instructions for use and precautions to be indicated on the label of treated goods under Article 528(2012), second subparagraph, point (e) of Regulation (EU) No 58
Tags:
Chemicals
